MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-07-2025
OptimizeRx Corporation Operating Income 2011-2026 | OPRX
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income OptimizeRx Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.4 M | -12.3 M | 361 K | -2.14 M | -3.69 M | 180 K | -2.13 M | -1.58 M | -597 K | -1.03 M | -268 K | -455 K | -1.45 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 361 K | -26.4 M | -3.96 M |
Quarterly Operating Income OptimizeRx Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.05 M | 3.19 M | -2.11 M | - | -8.56 M | -3.75 M | -5.03 M | - | -3.55 M | -4.85 M | -7.06 M | - | -3.76 M | -3.91 M | -3.76 M | - | 38.2 K | 340 K | -638 K | - | -177 K | -1.06 M | -2.26 M | - | -1.99 M | 480 K | 132 K | - | 223 K | 274 K | -191 K | - | -630 K | -371 K | -890 K | - | -249 K | -603 K | -362 K | - | 87.6 K | -158 K | -111 K | - | -295 K | -200 K | -762 K | - | -142 K | 354 K | 99.8 K | - | -106 K | -76.2 K | -301 K | - | 13.5 M | -420 K | -240 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 13.5 M | -8.56 M | -841 K |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | USA |
 |
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | USA |
 |
Evolent Health
EVH
|
3.64 M | $ 3.93 | 4.11 % | $ 368 M | USA |
 |
Akerna Corp.
KERN
|
-17.7 M | - | - | $ 161 M | USA |
 |
Health Catalyst
HCAT
|
-69.8 M | $ 2.2 | -4.76 % | $ 132 M | USA |
 |
HealthStream
HSTM
|
21.3 M | $ 21.27 | -2.48 % | $ 646 M | USA |
 |
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | USA |
 |
HealthEquity
HQY
|
118 M | $ 84.42 | -1.11 % | $ 7.22 B | USA |
 |
American Well Corporation
AMWL
|
-218 M | $ 4.64 | -2.52 % | $ 69.6 M | USA |
 |
MTBC
MTBC
|
9.12 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | USA |
 |
So-Young International
SY
|
-624 M | $ 2.69 | 0.56 % | $ 214 M |  China |
 |
GoodRx Holdings
GDRX
|
65.8 M | $ 2.6 | -3.17 % | $ 1 B | USA |
 |
Omnicell
OMCL
|
337 K | $ 49.14 | -2.73 % | $ 2.26 B | USA |
 |
Premier
PINC
|
1.12 M | - | - | $ 2.33 B | USA |
 |
Progyny
PGNY
|
15.8 M | $ 25.33 | 3.3 % | $ 2.17 B | USA |
 |
Phreesia
PHR
|
-136 M | $ 15.64 | -4.58 % | $ 853 M | USA |
 |
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | USA |
 |
Zhongchao
ZCMD
|
-341 K | $ 0.48 | -3.92 % | $ 2.5 M | China |
 |
Schrödinger
SDGR
|
-209 M | $ 16.37 | -2.5 % | $ 1.19 B | USA |
 |
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | USA |
 |
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | USA |
 |
10x Genomics
TXG
|
-265 M | $ 22.12 | 7.77 % | $ 2.59 B | USA |
 |
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
-1.02 B | $ 6.08 | -3.18 % | $ 1.04 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
429 M | $ 215.95 | -2.82 % | $ 34.7 B | USA |
 |
SCWorx Corp.
WORX
|
-1.26 M | $ 0.18 | -2.23 % | $ 263 K | USA |